Literature DB >> 3651263

Non-Hodgkin lymphoma. Multivariate analysis of prognostic factors including fraction of S-phase cells.

P Lenner1, G Roos, H Johansson, J Lindh, U Dige.   

Abstract

In a material of 80 patients with non-Hodgkin lymphoma a multivariate analysis was carried out taking the following variables into account: Age, clinical stage, B-symptoms, morphologic diagnosis and fraction of S-phase cells in the tumour determined by flow cytometry. Clinical stage, proportion of cells in the S-phase, and age of the patient were significant independent prognostic factors. Morphologic malignancy grade and B-symptoms were not significant parameters in this analysis. It was concluded that DNA analysis with determination of the fraction of S-phase cells is a valuable complement to morphology in the evaluation of patients with non-Hodgkin lymphoma. In combination with the clinical stage it gives very good discrimination into groups with different prognoses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3651263     DOI: 10.3109/02841868709091427

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

1.  Prognostic value of cytophotometric analysis of DNA in lymph node aspirates from patients with non-Hodgkin's lymphoma.

Authors:  J Vucković; M Dubravcić; J M Matthews; S N Wickramasinghe; M Dominis; B Jaksić
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

2.  Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.

Authors:  P J Klemi; K Alanen; S Jalkanen; H Joensuu
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

3.  Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.

Authors:  T Stokke; E B Smeland; S Kvaløy; H Holte
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

4.  Contribution of 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma.

Authors:  A Costa; R Silvestrini; R Giardini; G Messina-Gabrielli; P Boracchi; S Veneroni
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

5.  DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease.

Authors:  M Karlsson; B Boeryd; J Carstensen; B Kågedal; A T Bratel; S Wingren
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.